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ABSTRACT 
Sheetapitta is a clinical condition caused due to vitiation of Tridosha mainly by the contact 
of Sheetalavayu. It is characterized by Varati Damstravat Shotha (wheals), Kandu (itching), 
Daha (burning sensation), Toda (pricking pain), Jwara (fever) and Chardi (vomiting). 
Sheetapitta analogous to urticaria of western medicine. Urticaria is a vascular reaction 
pattern characterized by transient, erythematous and edematous wheals or papules of 
varying sizes and shapes which are usually pruritic. Episodes lasting more than 6 weeks 
are regarded as chronic urticaria. Present study is a single group open clinical trial with 
pre and post-test design with a sample size of 33 subjects. The diagnosis was based on the 
signs and symptoms of Sheetapitta vis-à-vis chronic urticaria and the assessment was 
based on Urticaria Activity Score which includes wheals and itch as its parameter. 
Subjects were administered with Virechana Karma followed by Ardraka Khandawith 
Amruta Rajanyadi Kashaya as Anupana for 30 days after Virechana Karma. The result 
obtained after the completion of intervention showed statistically highly significant with 
the P value 0.001 and also overall clinical improvement showed significant result in 
reducing the signs and symptoms of Sheetapitta vis-à-vis chronic urticaria. Sheetapitta 
being Tridoshajanya, Virechana Karma helped in Tridosha Nirharana (expelling dosha). 
Ardraka Khanda being Agnideepaka (appetiser), Sheeta Pittahara (disease pacifying 
action) and Rasayana (rejuvinator) followed by Amruta Rajanyadi Kashaya which is 
Kapha-Pitta Hara, Dahahara (reducing burning sensation) and Kanduhara (anti-itch) 
properties pacified the signs and symptoms of Sheetapitta. In combination of both 
Virechana Karma and Ardraka Khanda with Amruta- Rajanyadi Kashaya, majority of the 
subjects attained pacification of urticarial wheals and itching. 
KEYWORDS: Sheetapitta, Virechanakarma, Ardraka Khanda, Amrutarajanyadi Kashaya, 
Chronic urticaria, Urticaria Activity Score. 
INTRODUCTION 
Sheetapitta is a condition caused due to 
contact of Sheetala Vayu. This causes aggravation of 
Vata Dosha and Kapha Dosha and carry Pitta Dosha 
along with them and spreads externally to skin and 
internally to the Koshta leading to clinical 
manifestations. The clinical manifestations are Varati 
Damstravat Shotha (wheals), Kandu (itching), Daha 
(burning sensation), Toda (pricking pain), Jwara 
(fever) and Chardi (vomiting).[1] Urticaria is a 
vascular reaction of the skin characterized by the 
appearance of wheals, generally surrounded by a red 
halo or flare and associated with severe itching, 
stinging, or pricking sensations[2]. The lesion lasting 
longer than 6 weeks are considered as chronic 
urticaria[3]. Chronic urticaria is prevalent among 0.5-
1% of the adult population with female 
predominance[4]. The frequency is more observed 
after with the highest incidence in the third decade of 
life[5]. The causes of urticaria includes food and food 
additives, drugs, emotional stress, insect bite, contact 
of plants, focal sepsis, intestinal worms, immune 
regulation defects and physical factors such as heat, 
cold, sun, exertion, pressure and vibrations[6]. The 
pathology of urticaria mainly includes activation of 
mast cells. The activated mast cells release mediators 
such as histamine, serotonin and bradykinin which 
causes capillary dilatation and leakage of plasma 
leading to formation of wheals[7]. The management of 
chronic urticaria includes anti-histamines, gluco-
corticoids and immunoglobulin administration[8]. 
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Management of Sheetapitta mentioned in ayurvedic 
classics are Shodhana Chikitsa includes Vamana 
Karma (emetic therapy), Virechana Karma (purgation 
therapy) and Raktamokshana (blood-letting therapy). 
Shamana Chikitsa includes Abhyanga with KatuTaila 
(mustard oil) followed by UshnaJala Seka (hot water 
bath), Udwartana (powder massage) and various 
internal medications. Pathya mentioned for 
Sheetapitta are, Shushka Mulaka (dried Radish), 
Kulattha Rasa (soup of horse-gram), Lava (common 
quail) and Tittiri (patridge) variety of Mamsa Rasa[9]. 
OBJECTIVE OF THE STUDY  
To evaluate the combined effect of Virechana 
Karma, Ardraka Khanda and Amrutarajanyadi 
Kashaya in the management of Sheetapitta vis-à-vis 
chronic urticaria. 
MATERIALS AND METHODS 
Source of data 
Subjects were selected from the OPD and IPD of 
Government Ayurveda Medical College and Hospital, 
Mysuru and Government Hi–tech Panchakarma 
Hospital, Mysuru.  
Study design 
Single group open clinical trial with pre and post-
test design. Total 38 subjects were registered, there 
were 5 dropouts. The study was completed in 33 
subjects. 
Inclusion criteria 
1. Subjects of all gender, between the age group of 
18-60 years with the signs and symptoms of 
Sheetapitta vis-à-vis chronic urticaria were 
selected for the study. 
2. Freshly detected cases and treated cases (with 
the flush out period of 7 days) of Sheetapitta vis-
a-vis chronic urticaria were taken for the study. 
Exclusion criteria 
1. Subjects suffering from uncontrolled diabetes 
mellitus (>200mg/dl), uncontrolled hypertension 
(systolic>160mm Hg and diastolic > 90mmHg) 
and other systemic disorders which interfered 
with the course of intervention were excluded. 
2. Subjects unfit for Virechana Karma were 
excluded. 
3. Pregnant women and lactating mothers were 
excluded.  
Diagnostic Criteria 
The diagnosis was based on classical features of 
Sheetapitta vis-à-vis chronic urticaria. 
1. Varati Damshtravat Shotha(wheals) 
2. Kandu (itching) 
3. Toda (pricking pain) 
4. Vidaha (burning sensation) 
With or without 
5. Chardi (vomiting) 
6. Jwara (fever) 
Assessment criteria 
Assessment was done based on following parameter. 
Urticaria Activity Score[10] (UAS) – scoring 0-6. 
Grading of Number of Wheals. 
0 - None 
1 – Mild (< 20 / 24hours) 
2 – Moderate (21-50 / 24 hours) 
3 – Intense (>50 / 24hour) 
Grading of Severity of Itch – 
0 - None 
1 - Mild 
2 - Moderate 
3 – Intense / severe 
Statistical methods 
The results were analyzed statistically by 
using descriptive statistics and Cramer’s V test using 
Service product for statistical solution (SPSS) for 
windows software 
Intervention 
Amapachana was done with Ajamodadi 
Churna[11] 15gm of the drug was administered in 
three equally divided doses after food with warm 
water as Anupana till Nirama Lakshana were 
observed. Mahatiktaka Ghruta[12] was administered 
in a dose depending upon the Koshta of the subject 
from the day of Nirama Lakshana in Arohana Krama, 
starting with Hrasiyasi Matra until Samyak Snigdha 
Lakshana were observed. Katu Taila[13] Abhyanga 
followed by UshnaJala Snana[14] for 3 days in 
Vishrama Kala was given. TrivrutLehya[15] was 
administered in the morning hours on empty 
stomach for the purpose of Virechana. Dose varied 
between 40-70gms, depending upon the Koshta of 
the subject. After Atura Nireekshana, Samsarjana 
Krama was advised according to Shuddhi Prakara. 
Ardraka Khanda Avalehya[16] 12gms in two equally 
divided doses along with 40ml of Amruta Rajanyadi 
Kashaya[17] in two equally divided doses as Anupana 
after food for the next 30 days was administered.  
The assessment was done on the following three 
schedules 
Pre-test assessment: Before the commencement of 
intervention. 
Mid test assessment: After Virechana Karma 
Post-test assessment: 31st day after Shamana 
Aushadhi administration.
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OBSERVATIONS AND RESULTS 
The data was collected from the subjects based on diagnostic criteria and UAS criteria. The results were 
analysed statistically using Cramer’s V test. 
Varati Damshtravat Shotha 
Out of 33 subjects, all subjects presented with Varati Damshtravat Shotha. Before intervention, 14 
(42.4%) subjects had grade 1 severity, 6 (18.2%) subjects had grade 2 severity and 13 (39.4%) subjects had 
grade 3 severity. After the completion of intervention, 18 (54.5%) subjects had grade 0 severity, 7 (21.2%) 
subjects had grade 1 severity, 7 (21.2%) subjects had grade 2 severity and 1 (3%) subject had grade 3 severity. 
The result obtained regarding the parameter- Varati Damshtravat Shotha showed statistically highly significant 
with P value 0.001. 
Table 1: Showing the distribution and results on Varati Damshtravat Shotha 
 Session Total Test 
statistics  
BT M AT   
Shota 
.00 
Count 0 15 18 33  
% within Session 0.0% 45.5% 54.5% 33.3% 
CV- 0.416 
P=0.001 
1.00 
Count 14 9 7 30  
% within Session 42.4% 27.3% 21.2% 30.3%  
2.00 
Count 6 6 7 19  
% within Session 18.2% 18.2% 21.2% 19.2%  
3.00 
Count 13 3 1 17  
% within Session 39.4% 9.1% 3.0% 17.2%  
Total Count 33 33 33 99  
% within Session 100.0% 100.0% 100.0% 100.0%  
Kandu 
Out of 33 subjects, all subjects presented with Kandu. Before intervention, 3 (9.1%) subjects had grade 
1 severity, 19 (57.6%) subjects had grade 2 severity and 11 (33.3%) subjects had grade 3 severity. After the 
completion of intervention, 9 (27.3%) subjects had grade 0 severity, 16 (48.5%) subjects had grade 1 severity, 
7 (21.2%) subjects had grade 2 severity and 1 (3%) subject had grade 3 severity. The result obtained regarding 
the parameter- Kandu showed statistically highly significant with P value 0.001. 
Table 2: Showing the distribution and results on Kandu 
 Session Total Test 
statistics  BT M AT 
Kandu 
.00 
Count 0 7 9 16  
% within Session 0.0% 21.2% 27.3% 16.2% 
CV- 0.479 
P=0.001 
1.00 
Count 3 18 16 37  
% within Session 9.1% 54.5% 48.5% 37.4%  
2.00 
Count 19 8 7 34  
% within Session 57.6% 24.2% 21.2% 34.3%  
3.00 
Count 11 0 1 12  
% within Session 33.3% 0.0% 3.0% 12.1%  
Total 
Count 33 33 33 99  
% within Session 100.0% 100.0% 100.0% 100.0%  
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Daha 
Out of 33 subjects, 21 subjects presented with Daha. Before intervention, 14 (42.4%) subjects had grade 
1 severity, and 7 (21.2%) subjects had grade 2 severity. After the completion of intervention, 29 (87.9%) 
subjects had grade 0 severity and 4 (12.1%) subjects had grade 1 severity. The result obtained regarding the 
parameter- Daha showed statistically highly significant with P value 0.001. 
Table 3: Showing the distribution and results on Daha 
 Session Total Test statistics  
BT M AT 
Daha 
.00 
Count 12 24 29 65  
% within Session 36.4% 72.7% 87.9% 65.7%  
1.00 
Count 14 9 4 27  
% within Session 42.4% 27.3% 12.1% 27.3% 
CV- 0.367 
 P=0.001 
2.00 
Count 7 0 0 7  
% within Session 21.2% 0.0% 0.0% 7.1%  
Total 
Count 33 33 33 99  
% within Session 100.0% 100.0% 100.0% 100.0%  
Toda 
Out of 33 subjects, 26 subjects presented with Toda. Before intervention, 16 (48.5%) subjects had grade 
1 severity, 9 (27.3%) subjects had grade 2 severity and 1 (3%) subject had grade 3 severity. After the 
completion of intervention, 26 (78.8%) subjects had grade 0 severity and 7 (21.2%) subjects had grade 1 
severity. The result obtained regarding the parameter- Toda showed statistically highly significant with P value 
0.001. 
Table 4: Showing the distribution and results on Toda 
 Session Total Test 
statistics  
BT M AT   
Toda 
.00  
Count 7 20 26 53  
% within Session 21.2% 60.6% 78.8% 53.5% 
CV-0.394 
P=0.001 
1.00 
Count 16 12 7 35  
% within Session 48.5% 36.4% 21.2% 35.4%  
2.00 
Count 9 1 0 10  
% within Session 27.3% 3.0% 0.0% 10.1%  
3.00 
Count 1 0 0 1  
% within Session 3.0% 0.0% 0.0% 1.0%  
Total Count 33 33 33 33  
% within Session 100.0% 100.0% 100.0% 100.0%  
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Urticaria Activity Score (UAS) 
Table 5: Showing the distribution and results on Urticaria Activity Score 
 Session Total Test 
statistics BT M AT 
 
 
 
 
 
 
 
 
 
 
UAS 
.00 
Count 0 4 8 12  
% within Session 0.0% 12.1% 24.2% 12.1% 
CV-714 
P=0.001 
1.00 
Count 0 9 8 17  
% within Session 0.0% 27.3% 24.2% 17.2%  
2.00 
Count 1 13 9 23  
% within Session 3.0% 39.4% 27.3% 23.2%  
3.00 
Count 9 0 1 10  
% within Session 27.3% 0.0% 3.0% 10.1%  
4.00 
Count 11 6 5 22  
% within Session 33.3% 18.2% 15.2% 22.2%  
5.00 
Count 5 1 2 8  
% within Session 15.2% 3.0% 6.1% 8.1%  
6.00 
Count 7 0 0 7  
% within Session 21.2% 0.0% 0.0% 7.1%  
Total 
Count 33 33 33 99  
% within Session 100.0% 100.0% 100.0% 100.0%  
Out of 33 subjects, Before intervention, 0 
(0%) subject had grade 0 and grade 1 severity, 1 
(3%) subject had grade 2 severity, 9 (27.3%) subjects 
had grade 3 severity, 11 (33.3%)subjects had grade 4 
severity, 5 (15.2%) subjects had grade 5 severity and 
7 (21.2%) subjects had grade 6 severity. 
In mid assessment, 4 (12.1%)subjects had 
grade 0 severity, 9 (27.3%) subjects had grade 1 
severity, 13 (39.4%) subjects had grade 2 severity, 0 
(0%)subjects had grade 3 severity 6 (18.2%)subjects 
had grade 4 severity, 1 (3%) subject had grade 5 
severity and 0 (0%)subject had grade 6 severity. 
After the completion of intervention, 8 
(24.2%) subjects had grade 0 severity, 8 (24.2%) 
subjects had grade 1 severity, 9 (27.3%) subjects had 
grade 2 severity, 1 (3%)subjects had grade 3 severity, 
5 (15.2%) subjects had grade 4 severity, 2 subjects 
had grade 5 severity and 0 (0%)subject had grade 6 
severity. 
The result obtained regarding Urticaria 
Activity Score (UAS) showed statistically highly 
significant with P value 0.001. 
Overall clinical improvement 
The improvement was graded with following 
manner: 
Marked improvement- 76-100% relief from 
reduction of signs and symptoms. 
Moderate improvement- 51-75% relief from 
reduction of signs and symptoms.  
Mild improvement- 26-50% relief from reduction of 
signs and symptoms. 
No improvement- <25 % relief from reduction of 
signs and symptoms. 
Table 6: Showing the overall clinical 
improvement of Sheetapitta vis-à-vis chronic 
urticaria 
 Number of 
subjects  
Percentage  
Marked 
improvement  
10 31.31% 
Moderate 
improvement  
13 39.39% 
Mild 
improvement 
5 15.15% 
No improvement  5 15.15% 
Total  33 100% 
After the completion of the intervention, 10 
(31.31%) subjects had marked relief, 13 (39.39%) 
subjects had moderate relief, 5 (15.15%) subjects 
had mild relief and 5 (15.15%) subjects had no relief.  
 
 
 Chaithra HB et al. Evaluate the Combined Effect of Virechana Karma, Ardraka Khanda and Amruta Rajanyadi Kashaya in 
the Management of Sheetapitta 
     Available online at: http://ijapr.in  39 
DISCUSSION  
Sheetapitta is a Vata Pradhana 
Tridoshajavyadhi caused by the contact of 
Sheetalamaruta. In the present clinical trial, 
Sheetapitta is considered with special reference to 
chronic urticaria. Hence, all the variants of 
Sheetapitta mentioned in the classics i.e. Udarda and 
Kota are also included in the study. Though the Dosha 
involvement and causative factors are different, the 
management adopted in the clinical trial is classical 
Virechana Karma followed by Shamanoushadhi. The 
Ghruta exerts its action on Tridosha by “Samskarsaya 
Anuvartanat” property i.e. it adopts the properties of 
those drugs which are processed with it without 
losing its original property. Main purpose of 
Poorvakarma is to bring Dosha from Shakha to Koshta 
which is achieved by means of Vishyandana, Dosha 
Vriddi, Dosha Paka, Srotomukha Vishodhana and Vata 
Nirodha[18]. Swedana Karma helps in reducing 
Stambha, Sheeta and Gourava by the virtue of its 
Ushna, Laghu, Sara and Drava Guna. Sara and Drava 
Guna of Sweda does Dosha Vilayana and helps to 
bring Doshas from Shakha to Koshta.  
Vyavayi, Vikasi and Sookshma Guna of 
Virechana Yoga causes Dravya to reach minute 
channels. By virtue of Ushna and Teekshna Guna, it 
liquifies and separates the compacted morbid Dosha. 
By the effect of Pruthvi and Jala Mahabhuta, Gati of 
Dravya along with the Dosha will be towards 
Adhobhaga. In this way, Virechana Dravya 
consequently expels the Mala and Dosha from the 
body. Virechana expelled the aggravated Dosha 
especially Pitta and Kapha, which are the Dosha 
responsible for causing Kandu and Shotha. Here 
Kandu being the Swalakshana of both Pitta and 
Kapha, got relieved after the elimination of Pitta and 
Kapha[19]. Ardraka Khanda is being Agnideepaka, 
Sheeta Pittahara, and Rasayana[20]. Also, most of the 
individual drug of this yoga has Kanduhara, 
Kushtahara, Krimihara and Deepaniya properties 
which is similar with anti-histaminic, anti-
inflammatory, anti-helminthic, digestive and 
carminative properties. The digestive and 
carminative properties helped in prevention of 
further Ama formation. Anti-histaminic activity might 
have counteracted the histamines which are released 
from the degranulation of mast cells. Anti-helminthic 
property might have helped in destruction of 
intestinal parasites (which is also one of the reasons 
in the development of urticarial lesions) causing 
disease. Anti-inflammatory and anti-oxidant 
properties helped in reducing the inflammation and 
free radical generation from autoimmune response.  
The drugs of Amruta Rajanyadi Kashaya[21] 
are Kapha-Pitta hara by its Tikta Rasa Pradhana, by 
its Vishahara property it helped in detoxification of 
accumulated toxins in the form of histamines and 
leukotriens, by its Krimighna property acted as anti-
parasitic agent, by its Dahahara and Kanduhara 
action it pacified the symptoms of itching and 
burning sensation produced by the nerve stimulation, 
Kushta Prashamaka and Twak Mamsa Sthirakaraka 
action helped in normalising the skin by reducing the 
urticarial lesions. In combination of both Ardraka 
Khanda and Amruta-Rajanyadi Kashaya, majority of 
the patient has attained Twak Mamsa Sthireekarana 
and total pacification of urticarial lesion. 
CONCLUSION  
Sheetapitta is a Tridoshaja Vyadhi, causing 
Varati Damstravat Shotha, Kandu, Daha and Toda. 
Chronic urticaria is a condition in which urticaria 
lasts longer than 6 weeks of duration. The special 
reference of Sheetapitta is taken as chronic urticaria 
due to its similarities in its clinical features. There is 
scope for ayurvedic management in chronic stage 
than in acute stage, as acute urticaria has specific 
cause and there are high chances of spontaneous 
resolving of the condition, whereas chronic urticaria 
needs to be managed accordingly. Hence the 
comprehensive study was selected which involved 
the combined affects of Virechana Karma, Ardraka 
Khanda and Amruta Rajanyadi Kashaya. The result 
obtained in Sheetapitta vis-à-vis chronic urticaria 
after the completion of intervention showed 
statistically highly significant with the P value- 0.001 
and also overall improvement showed significant 
result in reducing the signs and symptoms of 
Sheetapitta vis-à-vis chronic urticaria. Hence 
Sheetapitta vis-à-vis chronic urticaria can be 
managed with present comprehensive ayurvedic 
management. 
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